114 related articles for article (PubMed ID: 37646571)
21. SUMO-interacting motifs (SIMs) in Polo-like kinase 1-interacting checkpoint helicase (PICH) ensure proper chromosome segregation during mitosis.
Sridharan V; Azuma Y
Cell Cycle; 2016 Aug; 15(16):2135-2144. PubMed ID: 27230136
[TBL] [Abstract][Full Text] [Related]
22. Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition.
Li LQ; Pan D; Chen Q; Zhang SW; Xie DY; Zheng XL; Chen H
Cell Physiol Biochem; 2018; 47(4):1533-1545. PubMed ID: 29940566
[TBL] [Abstract][Full Text] [Related]
23. The association between chemosensitivity and Pgp, GST-π and Topo II expression in gastric cancer.
Geng M; Wang L; Chen X; Cao R; Li P
Diagn Pathol; 2013 Dec; 8():198. PubMed ID: 24326092
[TBL] [Abstract][Full Text] [Related]
24. EBP50 gene transfection promotes 5-fluorouracil-induced apoptosis in gastric cancer cells through Bax- and Bcl-2-triggered mitochondrial pathways.
Lv XG; Ji MY; Dong WG; Lei XF; Liu M; Guo XF; Wang J; Fang C
Mol Med Rep; 2012 May; 5(5):1220-6. PubMed ID: 22366766
[TBL] [Abstract][Full Text] [Related]
25. Clinical Significance of Jagged-1 Activated by APEX1 as a Chemoresistance Factor in Advanced Gastric Cancer.
Kim HB; Lee HJ; Kim GB; Lim HJ; Park JH; Park SG
Anticancer Res; 2020 Apr; 40(4):1897-1904. PubMed ID: 32234878
[TBL] [Abstract][Full Text] [Related]
26. Targeting Plk1 to chromosome arms and regulating chromosome compaction by the PICH ATPase.
Leng M; Besusso D; Jung SY; Wang Y; Qin J
Cell Cycle; 2008 May; 7(10):1480-9. PubMed ID: 18418076
[TBL] [Abstract][Full Text] [Related]
27. CK1δ stimulates ubiquitination-dependent proteasomal degradation of ATF4 to promote chemoresistance in gastric Cancer.
Feng L; Li M; Hu X; Li Y; Zhu L; Chen M; Wei Q; Xu W; Zhou Q; Wang W; Chen D; Wang X; Jin H
Clin Transl Med; 2021 Oct; 11(10):e587. PubMed ID: 34709767
[TBL] [Abstract][Full Text] [Related]
28. The Significant Role of Cyclin D1 in the Synergistic Growth-inhibitory Effect of Combined Therapy of Vandetanib with 5-Fluorouracil for Gastric Cancer.
Yawata K; Osada S; Tanahashi T; Matsui S; Sasaki Y; Tanaka Y; Okumura N; Matsuhashi N; Takahashi T; Yamaguchi K; Yoshida K
Anticancer Res; 2016 Oct; 36(10):5215-5226. PubMed ID: 27798882
[TBL] [Abstract][Full Text] [Related]
29. [Correlation of chemosensitivity measured by histoculture drug response assay to expression of multidrug resistance genes and proteins in gastric cancer].
Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Keshari RP; Zhang LY
Ai Zheng; 2009 Apr; 28(4):337-43. PubMed ID: 19622290
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of MicroRNA-147 Inhibits Cell Proliferation and Increases the Chemosensitivity of Gastric Cancer Cells to 5-Fluorouracil by Directly Targeting PTEN.
Shen J; Niu W; Zhang H; Jun M; Zhang H
Oncol Res; 2018 Jul; 26(6):901-911. PubMed ID: 28950928
[TBL] [Abstract][Full Text] [Related]
31. Cell Cycle Dysregulation Is Associated With 5-Fluorouracil Resistance in Gastric Cancer Cells.
Kim DS; Min K; Lee SK
Anticancer Res; 2020 Jun; 40(6):3247-3254. PubMed ID: 32487619
[TBL] [Abstract][Full Text] [Related]
32. MiR-195 reverses 5-FU resistance through targeting HMGA1 in gastric cancer cells.
Wang CQ
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3771-3778. PubMed ID: 31115003
[TBL] [Abstract][Full Text] [Related]
33. Contribution of Epstein-Barr virus infection to chemoresistance of gastric carcinoma cells to 5-fluorouracil.
Seo JS; Kim TG; Hong YS; Chen JY; Lee SK
Arch Pharm Res; 2011 Apr; 34(4):635-43. PubMed ID: 21544729
[TBL] [Abstract][Full Text] [Related]
34. Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer.
Zhang S; Yang Y; Weng W; Guo B; Cai G; Ma Y; Cai S
J Exp Clin Cancer Res; 2019 Jan; 38(1):14. PubMed ID: 30630498
[TBL] [Abstract][Full Text] [Related]
35. Molecular marker identification for relapse prediction in 5-FU-based adjuvant chemotherapy in gastric and colorectal cancers.
Ishida K; Nishizuka SS; Chiba T; Ikeda M; Kume K; Endo F; Katagiri H; Matsuo T; Noda H; Iwaya T; Yamada N; Fujiwara H; Takahashi M; Itabashi T; Uesugi N; Maesawa C; Tamura G; Sugai T; Otsuka K; Koeda K; Wakabayashi G
PLoS One; 2012; 7(8):e43236. PubMed ID: 22905237
[TBL] [Abstract][Full Text] [Related]
36. Predicting the Efficacy of 5-Fluorouracil-Based Adjuvant Chemotherapy in Gastric Cancer by Microsatellite Instability: A Meta-Analysis.
Zhao F; Yuan X; Ren D; Shen G; Wang Z; Zheng F; Ahmad R; Ma Z; Zhao J
J Environ Pathol Toxicol Oncol; 2019; 38(1):21-28. PubMed ID: 30806287
[TBL] [Abstract][Full Text] [Related]
37. A miR-567-PIK3AP1-PI3K/AKT-c-Myc feedback loop regulates tumour growth and chemoresistance in gastric cancer.
Zhang F; Li K; Yao X; Wang H; Li W; Wu J; Li M; Zhou R; Xu L; Zhao L
EBioMedicine; 2019 Jun; 44():311-321. PubMed ID: 31078520
[TBL] [Abstract][Full Text] [Related]
38. Expression of orphan nuclear receptor NR4A2 in gastric cancer cells confers chemoresistance and predicts an unfavorable postoperative survival of gastric cancer patients with chemotherapy.
Han Y; Cai H; Ma L; Ding Y; Tan X; Chang W; Guan W; Liu Y; Shen Q; Yu Y; Zhang H; Cao G
Cancer; 2013 Oct; 119(19):3436-45. PubMed ID: 23821160
[TBL] [Abstract][Full Text] [Related]
39. Alarmin IL-33 orchestrates antitumoral T cell responses to enhance sensitivity to 5-fluorouracil in colorectal cancer.
Song M; Yang J; Di M; Hong Y; Pan Q; Du Y; Xiang T; Liu J; Tang Y; Wang Q; Li Y; He J; Chen H; Zhao J; Weng D; Zhang Y; Xia JC
Theranostics; 2023; 13(5):1649-1668. PubMed ID: 37056569
[No Abstract] [Full Text] [Related]
40. Thymidylate synthetase (TS) genotype and TS/dihydropyrimidine dehydrogenase mRNA level as an indicator in determining chemosensitivity to 5-fluorouracil in advanced gastric carcinoma.
Toriumi F; Kubota T; Saikawa Y; Yoshida M; Otani Y; Watanabe M; Kumai K; Kitajima M
Anticancer Res; 2004; 24(4):2455-63. PubMed ID: 15330198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
